GenePoly assist nucleic acid drug R&D

With the emergence of GalNAc delivery system and chemical modification technology, the delivery and stability of small nucleic acid have been initially solved, and small nucleic acid drugs have ushered in a new research and development boom. Domestic and foreign capital aiming at its huge market space and development potential, have layout, nucleic acid drug research and development has become a hot field in the world.

Figure 1 Chemical modifications of approved nucleic acid drugs 

     A series of chemical modifications and delivery systems help the research and development of nucleic acid drugs. At the same time, the company also provides Amino and Thiol linker of various lengths, which can be used for conjugation at various positions of the sequence, for conjugation of large molecular compounds, peptides, etc., to achieve more diversified nucleic acid drug research.